| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Xilio Therapeutics, Inc. Common Stock (NASDAQ: XLO)
XLO Technical Analysis
5
| As on 9th Jun 2023 XLO STOCK Price closed @ 2.86 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.71 & Strong Sell for SHORT-TERM with Stoploss of 12.98 we also expect STOCK to react on Following IMPORTANT LEVELS. |
XLOSTOCK Price
| Open | 3.25 | Change | Price | % |
| High | 3.25 | 1 Day | -0.14 | -4.67 |
| Low | 2.85 | 1 Week | -0.19 | -6.23 |
| Close | 2.86 | 1 Month | -0.19 | -6.23 |
| Volume | 3656 | 1 Year | -8.75 | -75.37 |
| 52 Week High 16.05 | 52 Week Low 1.97 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| XLO Daily Charts |
XLO Intraday Charts |
Whats New @ Bazaartrend |
XLO Free Analysis |
|
|
XLO Important Levels Intraday
| RESISTANCE | 3.63 |
| RESISTANCE | 3.38 |
| RESISTANCE | 3.23 |
| RESISTANCE | 3.08 |
| SUPPORT | 2.64 |
| SUPPORT | 2.49 |
| SUPPORT | 2.34 |
| SUPPORT | 2.09 |
XLO Forecast May 2024
| 4th UP Forecast | 16.06 |
| 3rd UP Forecast | 11.83 |
| 2nd UP Forecast | 9.21 |
| 1st UP Forecast | 6.59 |
| 1st DOWN Forecast | -0.87 |
| 2nd DOWN Forecast | -3.49 |
| 3rd DOWN Forecast | -6.11 |
| 4th DOWN Forecast | -10.34 |
XLO Weekly Forecast
| 4th UP Forecast | 5.94 |
| 3rd UP Forecast | 4.95 |
| 2nd UP Forecast | 4.34 |
| 1st UP Forecast | 3.73 |
| 1st DOWN Forecast | 1.99 |
| 2nd DOWN Forecast | 1.38 |
| 3rd DOWN Forecast | 0.77 |
| 4th DOWN Forecast | -0.22 |
XLO Forecast2024
| 4th UP Forecast | 31.73 |
| 3rd UP Forecast | 22.47 |
| 2nd UP Forecast | 16.75 |
| 1st UP Forecast | 11.02 |
| 1st DOWN Forecast | -5.3 |
| 2nd DOWN Forecast | -11.03 |
| 3rd DOWN Forecast | -16.75 |
| 4th DOWN Forecast | -26.01 |
Xilio Therapeutics, Inc. Common Stock ( NASDAQ USA Symbol : XLO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
XLO Business Profile
Xilio Therapeutics, Inc., a biotechnology company, designs immunotherapies to improve the immune system for cancer patients. Its checkpoint inhibitor programs include XTX101, is a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1 clinical trials in patients with solid tumors; and cytokine programs comprise XTX202, XTX301, and XTX401, which are modified form of IL-2 that is masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service